These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The role of T8 in the cytotoxic activity of cloned cytotoxic T lymphocyte lines specific for class II and class I major histocompatibility complex antigens. Spits H; Yssel H; Voordouw A; de Vries JE J Immunol; 1985 Apr; 134(4):2294-8. PubMed ID: 2579137 [TBL] [Abstract][Full Text] [Related]
23. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041 [TBL] [Abstract][Full Text] [Related]
24. Delineation of determinants on HLA-B7 and HLA-B27 that are necessary for cytolytic T cell recognition by using inter- and intra-domain recombinants. Healy F; Toubert A; Gomard E; Jordan BR; Levy JP J Immunol; 1989 Oct; 143(7):2357-63. PubMed ID: 2476507 [TBL] [Abstract][Full Text] [Related]
25. Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition. Villadangos JA; Galocha B; López D; Calvo V; López de Castro JA J Immunol; 1992 Jul; 149(2):505-10. PubMed ID: 1378067 [TBL] [Abstract][Full Text] [Related]
27. [HLA-B27 in Bechterew's disease]. Ulvestad E Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1317-22. PubMed ID: 10868094 [TBL] [Abstract][Full Text] [Related]
28. Subtypes of HLA-B27 detected by cytotoxic T lymphocytes and their role in self-recognition. Breuning MH; Lucas CJ; Breur BS; Engelsma MY; de Lange GG; Dekker AJ; Biddison WE; Ivanyi P Hum Immunol; 1982 Dec; 5(4):259-68. PubMed ID: 6186653 [TBL] [Abstract][Full Text] [Related]
29. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705. Villadangos JA; Galocha B; García-Hoyo R; López D; García F; López de Castro JA Eur J Immunol; 1994 Oct; 24(10):2548-55. PubMed ID: 7523146 [TBL] [Abstract][Full Text] [Related]
30. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111 [TBL] [Abstract][Full Text] [Related]
31. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Hermann E; Yu DT; Meyer zum Büschenfelde KH; Fleischer B Lancet; 1993 Sep; 342(8872):646-50. PubMed ID: 8103147 [TBL] [Abstract][Full Text] [Related]
32. T cell allorecognition and endogenous HLA-B27-bound peptides in a cell line with defective HLA-B27-restricted antigen presentation. López D; García-Hoyo R; García F; López de Castro JA Eur J Immunol; 1994 May; 24(5):1194-9. PubMed ID: 8181529 [TBL] [Abstract][Full Text] [Related]
33. HLA-B27-restricted antigen presentation by human chondrocytes to CD8+ T cells: potential contribution to local immunopathologic processes in ankylosing spondylitis. Kuhne M; Erben U; Schulze-Tanzil G; Köhler D; Wu P; Richter FJ; John T; Radbruch A; Sieper J; Appel H Arthritis Rheum; 2009 Jun; 60(6):1635-46. PubMed ID: 19479861 [TBL] [Abstract][Full Text] [Related]
34. HLA-B27 and disease: a consequence of inadvertent antigen presentation? Benjamin R; Parham P Rheum Dis Clin North Am; 1992 Feb; 18(1):11-21. PubMed ID: 1561398 [TBL] [Abstract][Full Text] [Related]
35. [Determination of HLA-B27 antigen subtypes from the results of lymphocyte reactions to anti-HLA-B27 sera]. Májský A Vnitr Lek; 1993 Jan; 39(1):49-53. PubMed ID: 8517042 [TBL] [Abstract][Full Text] [Related]
36. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line. Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184 [TBL] [Abstract][Full Text] [Related]
37. Usefulness of human leucocyte antigen-B27 subtypes in predicting ankylosing spondylitis: Taiwan experience. Hou TY; Chen HC; Chen CH; Chang DM; Liu FC; Lai JH Intern Med J; 2007 Nov; 37(11):749-52. PubMed ID: 17908086 [TBL] [Abstract][Full Text] [Related]
38. [Ankylosing spondylitis and heterogenity of HLA-B27 in Chinese]. Lin J; Lu H; Feng C Zhonghua Wai Ke Za Zhi; 1996 Jun; 34(6):333-5. PubMed ID: 9594171 [TBL] [Abstract][Full Text] [Related]
39. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis. Nicknam MH; Mahmoudi M; Amirzargar AA; Ganjalikhani Hakemi M; Khosravi F; Jamshidi AR; Amirkhani A; Ansaripour B; Pourpak Z; Moin M; Nikbin B Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):19-24. PubMed ID: 18322308 [TBL] [Abstract][Full Text] [Related]
40. HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707. Varnavidou-Nicolaidou A; Karpasitou K; Georgiou D; Stylianou G; Kokkofitou A; Michalis C; Constantina C; Gregoriadou C; Kyriakides G Hum Immunol; 2004 Dec; 65(12):1451-4. PubMed ID: 15603872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]